Loading…
Cardiff International, Inc. signed a Letter of Intent to acquire MedicaMetrix, Inc. in an all-stock transaction valued at approximately $6 million. MedicaMetrix is the creator of the ProstaMetric medical device for prostate cancer diagnosis.
“We are pleased to welcome MedicaMetrix to the Cardiff family.”meddeviceonline.com
Summarized from public sources; check the original articles before acting on it.